Related Experiment Video
Updated: Aug 11, 2026

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
[Aging, disease and nerve cell death]
1INSERM U 289, Hôpital de La Salpêtrière, Paris.
Abstract:
Apoptosis, or programmed cell death, is characterized by an active autodestruction of cells. Several proteins inducing (CED-3) or preventing (CED-9) neuronal death have been described in the nematode C. elegans. There is an homology between these proteins and Bcl-2 and ICE (Interleukin-1 beta-Converting Enzyme) in vertebrates. The cascade of biochemical events leading to this active neuronal "suicide" is triggered by initiating factors such as genotoxicity, growth factors deprivation, cytokines (TNF alpha). As the molecular mechanisms of nerve cell death start to be understood, clinicians and neurobiologists are confronted with the difficult problem of pathological aging and neuronal death in patients with neurodegenerative disorders compared to normal aging. In order to distinguish the biochemical abnormalities underlying dysfunction of neurons during aging, neuronal loss during neurodegeneration (Parkinson's disease) and nerve cell death, we searched for morphological and biochemical signs of apoptosis in dopaminergic neurons of the substantia nigra of parkinsonian patients and controls. We found characteristic histopathological features of apoptosis in about 5% of dopaminergic neurons in the brain of patients. In addition, the presence of TNF alpha receptors and the expression of the gene bcl-2 were observed in dopaminergic neurons. Thus, apoptosis could represent the ultimate step of dopaminergic neuronal degeneration in Parkinson's disease. Whether this is also the case in other neurodegenerative diseases still remains to be proven. In brief, neurons in the human brain could be classified into three categories: those which loose slowly part of their functions but are still spared by the process of neuronal death (senescence); those which are lost more rapidly than similar effects due to aging (neurodegeneration); a small number of neurons which die rapidly through apoptosis. The consequences of such observation may be important both for neurobiologists and pharmacologists as the basic mechanisms which result in senescence, disease and death of neurons could be different.
Insights
Apoptosis, or programmed cell death, is a key process in neurodegeneration. This study found apoptosis in dopaminergic neurons of Parkinson's disease patients, suggesting it may be the final step in their degeneration.
Area of Science:
- Neurobiology
- Cell Biology
- Biochemistry
Context:
- Apoptosis, or programmed cell death, involves active cellular self-destruction.
- Homologies exist between nematode cell death proteins (CED-3, CED-9) and vertebrate proteins (Bcl-2, ICE).
- Initiating factors for apoptosis include genotoxicity, growth factor deprivation, and cytokines like TNF alpha.
Purpose:
- To investigate the role of apoptosis in Parkinson's disease by examining dopaminergic neurons.
- To differentiate biochemical abnormalities in aging, neurodegeneration, and normal nerve cell death.
- To identify morphological and biochemical signs of apoptosis in the substantia nigra of Parkinson's patients and controls.
Summary:
- Histopathological signs of apoptosis were observed in approximately 5% of dopaminergic neurons in Parkinson's patients.
- TNF alpha receptors and bcl-2 gene expression were detected in these dopaminergic neurons.
- Apoptosis may represent the terminal stage of dopaminergic neuronal degeneration in Parkinson's disease.
Impact:
- Findings suggest distinct mechanisms for neuronal senescence, neurodegeneration, and apoptosis.
- Understanding these mechanisms could inform neurobiologists and pharmacologists.
- This research highlights apoptosis as a potential therapeutic target in Parkinson's disease and other neurodegenerative disorders.
Related Concept Videos
Neural Regulation
Neurogenesis and Regeneration of Nervous Tissue
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Diabetic Neuropathy
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology

